Cart
sales@molnova.com
Methyl homoveratrate
CAS No. 15964-79-1
Methyl homoveratrate( —— )
Catalog No. M26295 CAS No. 15964-79-1
Methyl homoveratrate is a metabolite of McN5691 in plasma, urine and faecal extract. McN5691 is a voltage-sensitive calcium channel blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | 35 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 82 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMethyl homoveratrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethyl homoveratrate is a metabolite of McN5691 in plasma, urine and faecal extract. McN5691 is a voltage-sensitive calcium channel blocker.
-
DescriptionMethyl homoveratrate is a metabolite of McN5691 in plasma, urine and faecal extract. McN5691 is a voltage-sensitive calcium channel blocker.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number15964-79-1
-
Formula Weight210.229
-
Molecular FormulaC11H14O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (475.67 mM)
-
SMILESCOC(=O)Cc1ccc(OC)c(OC)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Van Scoy AR, Tjeerdema RS. Environmental fate and toxicology of clomazone. Rev Environ Contam Toxicol. 2014;229:35-49.
molnova catalog
related products
-
Phenyl-Ac-Gln-OH
Phenylacetylglutamine is a normal constituent of human urine but other mammals such as the dog cat rat monkey sheep and horse do not excrete this compound. Phenylacetylglutamine is a major nitrogenous metabolite that accumulates in uremia. Phenylacetylglutamine also is a microbial metabolite found in Christensenellaceae Lachnospiraceae and Ruminococcaceae.
-
(S,R,S)-AHPC-Me-C10-...
(S,R,S)-AHPC-Me-C10-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate incorporating a VHL ligand and a linker.
-
LSP-249
LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
